GREENWOOD VILLAGE, Colo. & LOS ANGELES–(BUSINESS WIRE)– ANANDA Scientific Inc., a research focused bio-pharmaceutical company, and the Semel Institute for Neuroscience at Geffen School of Medicine UCLA today announced the commencement of a clinical trial evaluating Nantheia™ ATL5, an investigational drug combining cannabidiol (CBD) with ANANDA’s proprietary delivery technology, to evaluate the efficacy of cannabidiol for smoking cessation. (Clinical Trials.gov… Continue reading ANANDA Scientific and the David Geffen School of Medicine, UCLA, Announce Commencement of a Clinical Trial Evaluating Nantheia™ ATL5 for Smoking Cessation
ANANDA Scientific and the David Geffen School of Medicine, UCLA, Announce Commencement of a Clinical Trial Evaluating Nantheia™ ATL5 for Smoking Cessation
